No Data
Scholar Rock Holding Stock Jumps 293% After Spinal Drug Trial
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating, Announces Target Price $36
Health Care Losses Limited By Defensive Bias - Health Care Roundup
After-hours Movers: PENN Entertainment, Scholar Rock, and More
Scholar Rock Announces $275M Common Stock Offering
Express News | Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants